Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 28;37(3):208-209.
doi: 10.4274/tjh.galenos.2020.2019.0180. Epub 2020 Apr 6.

Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia

Gülşen İskender  1 , Dicle İskender  2 , Mustafa Ertek  1
Affiliations
Case Reports

Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia

Gülşen İskender et al. Turk J Haematol. .
No abstract available

Keywords: Hepatitis B reactivation; Ibrutinib; Chronic lymphocytic leukemia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.

Figures

Figure 1
Figure 1
Summarized course of the disease. HBsAg: Hepatitis B surface antigen.
See this image and copyright information in PMC

References

    1. Aygen B, Demir AM, Gümüş M, Karabay O, Kaymakoğlu S, Köksal AŞ, Köksal İ, Örmeci N, Tabak F. Immunosuppressive therapy and the risk of hepatitis B reactivation: consensus report. Turk J Gastroenterol. 2018;29:259–269. - PMC - PubMed
    1. Reddy KR, Beavers KL, Hammond SP, Lim JK, Falck-Ytter YT; American Gastroenterological Association Institute. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology. 2015;148:215–219. - PubMed
    1. Varma G, Johnson TP, Advani RH. Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia and lymphoma. Clin Adv Hematol Oncol. 2016;14:543–554. - PubMed
    1. Mallet V, van Bömmel F, Doerig C, Pischke S, Hermine O, Locasciulli A, Cordonnier C, Berg T, Moradpour D, Wedemeyer H, Ljungman P; ECIL-5. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haematopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5) Lancet Infect Dis. 2016;16:606–617. - PubMed
    1. de Jésus Ngoma P, Kabamba B, Dahlqvist G, Sempoux C, Lanthier N, Shindano T, Van Den Neste E, Horsmans Y. Occult HBV reactivation induced by ibrutinib treatment: a case report. Acta Gastroenterol Belg. 2015;78:424–426. - PubMed

Publication types

MeSH terms

LinkOut - more resources